Economic evaluation of agomelatine relative to other antidepressants for treatment of major depressive disorders in Greece

BACKGROUND: Major depressive disorder (MDD) constitutes an important public health problem, as it is highly prevalent in the industrialized world and it is associated with substantial economic consequences for patients, health care providers, insurance and social security organizations and employers...

Descripción completa

Detalles Bibliográficos
Autores principales: Maniadakis, Nikos, Kourlaba, Georgia, Mougiakos, Theodoros, Chatzimanolis, Ioannis, Jonsson, Linus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3654993/
https://www.ncbi.nlm.nih.gov/pubmed/23663281
http://dx.doi.org/10.1186/1472-6963-13-173

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3654993/
https://www.ncbi.nlm.nih.gov/pubmed/23663281
http://dx.doi.org/10.1186/1472-6963-13-173

Ejemplares similares